About Kredenz Pharma
Kredenz Pharma was a Healthcare company based in Hyderabad (India) founded in 2016 by Rajagopalan Parthasarathy, Jagan Reddy, and Madhuker Vempalla. It manufactures active pharmaceutical ingredients and intermediates for the industry. It operates on a B2B model. Its Indian entity Kredenz Pharma Private Limited reported revenue of ₹11 Lakh. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Manufacturing and API Production. Similar companies include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent and 4 more; 4 of its 9 listed similar companies have raised funding.
Company details
Kredenz Pharma, based in Hyderabad, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api production. Manufactures active pharmaceutical ingredients and intermediates for the industry. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Hyderabad, India
- Founders Rajagopalan Parthasarathy, Jagan Reddy, Madhuker Vempalla
- SectorsHealthcare
- Website kredenzpharma.com
- Legal Name Kredenz Pharma Private Limited
- Date of Incorporation 25 May, 2016
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹11 Lakh
FY 2025 · +40% YoY
- Net Profit₹1.3 Lakh
FY 2025 · 11% margin
- EBITDA₹1.5 Lakh
FY 2025 · 14% margin
Associated legal entities of Kredenz Pharma
Kredenz Pharma operates through Kredenz Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kredenz Pharma Private Limited CIN U24290TG2016PTC109885 | Active | 25 May 2016 | Hyderabad, Telangana | ₹0.1 Cr | – | 3 | View details |
Board of directors of Kredenz Pharma Private Limited (Kredenz Pharma)
Kredenz Pharma Private Limited is the primary company behind Kredenz Pharma. The board of Kredenz Pharma Private Limited currently have 3 directors; the longest-serving is Madhukar Vempalla, appointed in 2016.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Madhukar Vempalla DIN 03193474 | Director | 25 May 2016 | 10 yrs 4 mo | Kredenz Pharma Private Limited |
| Parthasarathy Rajagopalan DIN 06770684 | Director | 25 May 2016 | 10 yrs 4 mo | Kredenz Pharma Private Limited |
| Jagan Mohan Reddy Narsa Reddy DIN 07508070 | Director | 25 May 2016 | 10 yrs 4 mo | Kredenz Pharma Private Limited |
People of Kredenz Pharma
3 people are tracked at Kredenz Pharma (3 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership | |
Madhuker Vempalla | Co-Founder | Leadership |
Complete people profiles for Kredenz Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Kredenz Pharma
Figures of Kredenz Pharma Private Limited, the primary company behind Kredenz Pharma, for FY 2025. Revenue was ₹11 Lakh (+40% year on year). Net profit was ₹1.3 Lakh (11% margin). EBITDA was ₹1.5 Lakh (14% margin).
- ₹11 LakhRevenue · FY 2025 · +40% YoY
- ₹1.3 LakhNet profit · 11% margin
- ₹1.5 LakhEBITDA · 14% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Kredenz Pharma Private Limited are on its company page.
Detailed financial statements for Kredenz Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Kredenz Pharma
Kredenz Pharma has 9 listed similar companies in our database, 4 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed similar companies of Kredenz Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Kredenz Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kredenz Pharma
Kredenz Pharma was founded in 2016.
Kredenz Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Kredenz Pharma, Kredenz Pharma Private Limited, reported revenue of ₹11 Lakh for FY 2025, up 40% year on year.
Kredenz Pharma, based in Hyderabad, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api production. Manufactures active pharmaceutical ingredients and intermediates for the industry. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Kredenz Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Kredenz Pharma operates through Kredenz Pharma Private Limited.
The legal entities of Kredenz Pharma currently have 3 directors, including Madhukar Vempalla, Parthasarathy Rajagopalan, Jagan Mohan Reddy Narsa Reddy.